Global Specialty Pharmaceutical Market Research Report 2021

SKU ID :QYR-19356537 | Published Date: 18-Oct-2021 | No. of pages: 126
1 Specialty Pharmaceutical Market Overview 1.1 Product Overview and Scope of Specialty Pharmaceutical 1.2 Specialty Pharmaceutical Segment by Type 1.2.1 Global Specialty Pharmaceutical Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Antibody 1.2.3 Hormone 1.2.4 Growth Factors 1.2.5 Other 1.3 Specialty Pharmaceutical Segment by Application 1.3.1 Global Specialty Pharmaceutical Sales Comparison by Application: (2021-2027) 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Other 1.4 Global Specialty Pharmaceutical Market Size Estimates and Forecasts 1.4.1 Global Specialty Pharmaceutical Revenue 2016-2027 1.4.2 Global Specialty Pharmaceutical Sales 2016-2027 1.4.3 Specialty Pharmaceutical Market Size by Region: 2016 Versus 2021 Versus 2027 2 Specialty Pharmaceutical Market Competition by Manufacturers 2.1 Global Specialty Pharmaceutical Sales Market Share by Manufacturers (2016-2021) 2.2 Global Specialty Pharmaceutical Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Specialty Pharmaceutical Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Specialty Pharmaceutical Manufacturing Sites, Area Served, Product Type 2.5 Specialty Pharmaceutical Market Competitive Situation and Trends 2.5.1 Specialty Pharmaceutical Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Specialty Pharmaceutical Players Market Share by Revenue 2.5.3 Global Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Specialty Pharmaceutical Retrospective Market Scenario by Region 3.1 Global Specialty Pharmaceutical Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Specialty Pharmaceutical Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Specialty Pharmaceutical Market Facts & Figures by Country 3.3.1 North America Specialty Pharmaceutical Sales by Country 3.3.2 North America Specialty Pharmaceutical Revenue by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Specialty Pharmaceutical Market Facts & Figures by Country 3.4.1 Europe Specialty Pharmaceutical Sales by Country 3.4.2 Europe Specialty Pharmaceutical Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Specialty Pharmaceutical Market Facts & Figures by Region 3.5.1 Asia Pacific Specialty Pharmaceutical Sales by Region 3.5.2 Asia Pacific Specialty Pharmaceutical Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Specialty Pharmaceutical Market Facts & Figures by Country 3.6.1 Latin America Specialty Pharmaceutical Sales by Country 3.6.2 Latin America Specialty Pharmaceutical Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Specialty Pharmaceutical Market Facts & Figures by Country 3.7.1 Middle East and Africa Specialty Pharmaceutical Sales by Country 3.7.2 Middle East and Africa Specialty Pharmaceutical Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Specialty Pharmaceutical Historic Market Analysis by Type 4.1 Global Specialty Pharmaceutical Sales Market Share by Type (2016-2021) 4.2 Global Specialty Pharmaceutical Revenue Market Share by Type (2016-2021) 4.3 Global Specialty Pharmaceutical Price by Type (2016-2021) 5 Global Specialty Pharmaceutical Historic Market Analysis by Application 5.1 Global Specialty Pharmaceutical Sales Market Share by Application (2016-2021) 5.2 Global Specialty Pharmaceutical Revenue Market Share by Application (2016-2021) 5.3 Global Specialty Pharmaceutical Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Specialty Pharmaceutical Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Roche 6.2.1 Roche Corporation Information 6.2.2 Roche Description and Business Overview 6.2.3 Roche Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Roche Specialty Pharmaceutical Product Portfolio 6.2.5 Roche Recent Developments/Updates 6.3 Amgen 6.3.1 Amgen Corporation Information 6.3.2 Amgen Description and Business Overview 6.3.3 Amgen Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Amgen Specialty Pharmaceutical Product Portfolio 6.3.5 Amgen Recent Developments/Updates 6.4 AbbVie 6.4.1 AbbVie Corporation Information 6.4.2 AbbVie Description and Business Overview 6.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.4.4 AbbVie Specialty Pharmaceutical Product Portfolio 6.4.5 AbbVie Recent Developments/Updates 6.5 Novo Nordisk 6.5.1 Novo Nordisk Corporation Information 6.5.2 Novo Nordisk Description and Business Overview 6.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novo Nordisk Specialty Pharmaceutical Product Portfolio 6.5.5 Novo Nordisk Recent Developments/Updates 6.6 Johnson & Johnson 6.6.1 Johnson & Johnson Corporation Information 6.6.2 Johnson & Johnson Description and Business Overview 6.6.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Johnson & Johnson Specialty Pharmaceutical Product Portfolio 6.6.5 Johnson & Johnson Recent Developments/Updates 6.7 Sanofi-Aventis 6.6.1 Sanofi-Aventis Corporation Information 6.6.2 Sanofi-Aventis Description and Business Overview 6.6.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi-Aventis Specialty Pharmaceutical Product Portfolio 6.7.5 Sanofi-Aventis Recent Developments/Updates 6.8 Merck 6.8.1 Merck Corporation Information 6.8.2 Merck Description and Business Overview 6.8.3 Merck Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Merck Specialty Pharmaceutical Product Portfolio 6.8.5 Merck Recent Developments/Updates 6.9 Eli Lilly 6.9.1 Eli Lilly Corporation Information 6.9.2 Eli Lilly Description and Business Overview 6.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Eli Lilly Specialty Pharmaceutical Product Portfolio 6.9.5 Eli Lilly Recent Developments/Updates 6.10 Novartis 6.10.1 Novartis Corporation Information 6.10.2 Novartis Description and Business Overview 6.10.3 Novartis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis Specialty Pharmaceutical Product Portfolio 6.10.5 Novartis Recent Developments/Updates 6.11 3sbio 6.11.1 3sbio Corporation Information 6.11.2 3sbio Specialty Pharmaceutical Description and Business Overview 6.11.3 3sbio Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.11.4 3sbio Specialty Pharmaceutical Product Portfolio 6.11.5 3sbio Recent Developments/Updates 6.12 Changchun High Tech 6.12.1 Changchun High Tech Corporation Information 6.12.2 Changchun High Tech Specialty Pharmaceutical Description and Business Overview 6.12.3 Changchun High Tech Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Changchun High Tech Specialty Pharmaceutical Product Portfolio 6.12.5 Changchun High Tech Recent Developments/Updates 6.13 CP Guojian Pharmacy 6.13.1 CP Guojian Pharmacy Corporation Information 6.13.2 CP Guojian Pharmacy Specialty Pharmaceutical Description and Business Overview 6.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.13.4 CP Guojian Pharmacy Specialty Pharmaceutical Product Portfolio 6.13.5 CP Guojian Pharmacy Recent Developments/Updates 6.14 Biotech Pharma 6.14.1 Biotech Pharma Corporation Information 6.14.2 Biotech Pharma Specialty Pharmaceutical Description and Business Overview 6.14.3 Biotech Pharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Biotech Pharma Specialty Pharmaceutical Product Portfolio 6.14.5 Biotech Pharma Recent Developments/Updates 6.15 Gelgen Biopharma 6.15.1 Gelgen Biopharma Corporation Information 6.15.2 Gelgen Biopharma Specialty Pharmaceutical Description and Business Overview 6.15.3 Gelgen Biopharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Gelgen Biopharma Specialty Pharmaceutical Product Portfolio 6.15.5 Gelgen Biopharma Recent Developments/Updates 6.16 Innovent 6.16.1 Innovent Corporation Information 6.16.2 Innovent Specialty Pharmaceutical Description and Business Overview 6.16.3 Innovent Specialty Pharmaceutical Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Innovent Specialty Pharmaceutical Product Portfolio 6.16.5 Innovent Recent Developments/Updates 7 Specialty Pharmaceutical Manufacturing Cost Analysis 7.1 Specialty Pharmaceutical Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Specialty Pharmaceutical 7.4 Specialty Pharmaceutical Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Specialty Pharmaceutical Distributors List 8.3 Specialty Pharmaceutical Customers 9 Specialty Pharmaceutical Market Dynamics 9.1 Specialty Pharmaceutical Industry Trends 9.2 Specialty Pharmaceutical Growth Drivers 9.3 Specialty Pharmaceutical Market Challenges 9.4 Specialty Pharmaceutical Market Restraints 10 Global Market Forecast 10.1 Specialty Pharmaceutical Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Specialty Pharmaceutical by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Specialty Pharmaceutical by Type (2022-2027) 10.2 Specialty Pharmaceutical Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Specialty Pharmaceutical by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Specialty Pharmaceutical by Application (2022-2027) 10.3 Specialty Pharmaceutical Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Specialty Pharmaceutical by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Specialty Pharmaceutical by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Specialty Pharmaceutical Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Specialty Pharmaceutical Sales (MT) Comparison by Application (2021-2027) Table 3. Global Specialty Pharmaceutical Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Specialty Pharmaceutical Covered in This Study Table 5. Global Specialty Pharmaceutical Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Specialty Pharmaceutical Sales Market Share by Manufacturers (2016-2021) Table 7. Global Specialty Pharmaceutical Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Specialty Pharmaceutical Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Specialty Pharmaceutical Average Price (USD/Kg) of Key Manufacturers (2016-2021) Table 10. Manufacturers Specialty Pharmaceutical Manufacturing Sites and Area Served Table 11. Manufacturers Specialty Pharmaceutical Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Specialty Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Pharmaceutical as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Specialty Pharmaceutical Sales by Region (2016-2021) & (MT) Table 16. Global Specialty Pharmaceutical Sales Market Share by Region (2016-2021) Table 17. Global Specialty Pharmaceutical Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Specialty Pharmaceutical Sales by Country (2016-2021) & (MT) Table 19. North America Specialty Pharmaceutical Sales Market Share by Country (2016-2021) Table 20. North America Specialty Pharmaceutical Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Specialty Pharmaceutical Revenue Market Share by Country (2016-2021) Table 22. Europe Specialty Pharmaceutical Sales by Country (2016-2021) & (MT) Table 23. Europe Specialty Pharmaceutical Sales Market Share by Country (2016-2021) Table 24. Europe Specialty Pharmaceutical Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Specialty Pharmaceutical Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Specialty Pharmaceutical Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Specialty Pharmaceutical Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Specialty Pharmaceutical Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Specialty Pharmaceutical Revenue Market Share by Region (2016-2021) Table 30. Latin America Specialty Pharmaceutical Sales by Country (2016-2021) & (MT) Table 31. Latin America Specialty Pharmaceutical Sales Market Share by Country (2016-2021) Table 32. Latin America Specialty Pharmaceutical Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Specialty Pharmaceutical Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Specialty Pharmaceutical Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Specialty Pharmaceutical Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Specialty Pharmaceutical Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Specialty Pharmaceutical Revenue Market Share by Country (2016-2021) Table 38. Global Specialty Pharmaceutical Sales (MT) by Type (2016-2021) Table 39. Global Specialty Pharmaceutical Sales Market Share by Type (2016-2021) Table 40. Global Specialty Pharmaceutical Revenue (Million US$) by Type (2016-2021) Table 41. Global Specialty Pharmaceutical Revenue Share by Type (2016-2021) Table 42. Global Specialty Pharmaceutical Price (USD/Kg) by Type (2016-2021) Table 43. Global Specialty Pharmaceutical Sales (MT) by Application (2016-2021) Table 44. Global Specialty Pharmaceutical Sales Market Share by Application (2016-2021) Table 45. Global Specialty Pharmaceutical Revenue (Million US$) by Application (2016-2021) Table 46. Global Specialty Pharmaceutical Revenue Share by Application (2016-2021) Table 47. Global Specialty Pharmaceutical Price (USD/Kg) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 51. Pfizer Specialty Pharmaceutical Product Table 52. Pfizer Recent Developments/Updates Table 53. Roche Corporation Information Table 54. Roche Description and Business Overview Table 55. Roche Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 56. Roche Specialty Pharmaceutical Product Table 57. Roche Recent Developments/Updates Table 58. Amgen Corporation Information Table 59. Amgen Description and Business Overview Table 60. Amgen Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 61. Amgen Specialty Pharmaceutical Product Table 62. Amgen Recent Developments/Updates Table 63. AbbVie Corporation Information Table 64. AbbVie Description and Business Overview Table 65. AbbVie Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 66. AbbVie Specialty Pharmaceutical Product Table 67. AbbVie Recent Developments/Updates Table 68. Novo Nordisk Corporation Information Table 69. Novo Nordisk Description and Business Overview Table 70. Novo Nordisk Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 71. Novo Nordisk Specialty Pharmaceutical Product Table 72. Novo Nordisk Recent Developments/Updates Table 73. Johnson & Johnson Corporation Information Table 74. Johnson & Johnson Description and Business Overview Table 75. Johnson & Johnson Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 76. Johnson & Johnson Specialty Pharmaceutical Product Table 77. Johnson & Johnson Recent Developments/Updates Table 78. Sanofi-Aventis Corporation Information Table 79. Sanofi-Aventis Description and Business Overview Table 80. Sanofi-Aventis Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 81. Sanofi-Aventis Specialty Pharmaceutical Product Table 82. Sanofi-Aventis Recent Developments/Updates Table 83. Merck Corporation Information Table 84. Merck Description and Business Overview Table 85. Merck Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 86. Merck Specialty Pharmaceutical Product Table 87. Merck Recent Developments/Updates Table 88. Eli Lilly Corporation Information Table 89. Eli Lilly Description and Business Overview Table 90. Eli Lilly Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 91. Eli Lilly Specialty Pharmaceutical Product Table 92. Eli Lilly Recent Developments/Updates Table 93. Novartis Corporation Information Table 94. Novartis Description and Business Overview Table 95. Novartis Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 96. Novartis Specialty Pharmaceutical Product Table 97. Novartis Recent Developments/Updates Table 98. 3sbio Corporation Information Table 99. 3sbio Description and Business Overview Table 100. 3sbio Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 101. 3sbio Specialty Pharmaceutical Product Table 102. 3sbio Recent Developments/Updates Table 103. Changchun High Tech Corporation Information Table 104. Changchun High Tech Description and Business Overview Table 105. Changchun High Tech Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 106. Changchun High Tech Specialty Pharmaceutical Product Table 107. Changchun High Tech Recent Developments/Updates Table 108. CP Guojian Pharmacy Corporation Information Table 109. CP Guojian Pharmacy Description and Business Overview Table 110. CP Guojian Pharmacy Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 111. CP Guojian Pharmacy Specialty Pharmaceutical Product Table 112. CP Guojian Pharmacy Recent Developments/Updates Table 113. Biotech Pharma Corporation Information Table 114. Biotech Pharma Description and Business Overview Table 115. Biotech Pharma Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 116. Biotech Pharma Specialty Pharmaceutical Product Table 117. Biotech Pharma Recent Developments/Updates Table 118. Gelgen Biopharma Corporation Information Table 119. Gelgen Biopharma Description and Business Overview Table 120. Gelgen Biopharma Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 121. Gelgen Biopharma Specialty Pharmaceutical Product Table 122. Gelgen Biopharma Recent Developments/Updates Table 123. Innovent Corporation Information Table 124. Innovent Description and Business Overview Table 125. Innovent Specialty Pharmaceutical Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 126. Innovent Specialty Pharmaceutical Product Table 127. Innovent Recent Developments/Updates Table 128. Production Base and Market Concentration Rate of Raw Material Table 129. Key Suppliers of Raw Materials Table 130. Specialty Pharmaceutical Distributors List Table 131. Specialty Pharmaceutical Customers List Table 132. Specialty Pharmaceutical Market Trends Table 133. Specialty Pharmaceutical Growth Drivers Table 134. Specialty Pharmaceutical Market Challenges Table 135. Specialty Pharmaceutical Market Restraints Table 136. Global Specialty Pharmaceutical Sales Forecast by Type (2022-2027) & (MT) Table 137. Global Specialty Pharmaceutical Sales Market Share Forecast by Type (2022-2027) Table 138. Global Specialty Pharmaceutical Revenue Forecast by Type (2022-2027) & (US$ Million) Table 139. Global Specialty Pharmaceutical Revenue Market Share Forecast by Type (2022-2027) Table 140. Global Specialty Pharmaceutical Sales Forecast by Application (2022-2027) & (MT) Table 141. Global Specialty Pharmaceutical Sales Market Share Forecast by Application (2022-2027) Table 142. Global Specialty Pharmaceutical Revenue Forecast by Application (2022-2027) & (US$ Million) Table 143. Global Specialty Pharmaceutical Revenue Market Share Forecast by Application (2022-2027) Table 144. Global Specialty Pharmaceutical Sales Forecast by Region (2022-2027) & (MT) Table 145. Global Specialty Pharmaceutical Sales Market Share Forecast by Region (2022-2027) Table 146. Global Specialty Pharmaceutical Revenue Forecast by Region (2022-2027) & (US$ Million) Table 147. Global Specialty Pharmaceutical Revenue Market Share Forecast by Region (2022-2027) Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Specialty Pharmaceutical Figure 2. Global Specialty Pharmaceutical Market Share by Type in 2020 & 2027 Figure 3. Antibody Product Picture Figure 4. Hormone Product Picture Figure 5. Growth Factors Product Picture Figure 6. Other Product Picture Figure 7. Global Specialty Pharmaceutical Market Share by Application in 2020 & 2027 Figure 8. Tumor Figure 9. Diabetes Figure 10. Cardiovascular Figure 11. Hemophilia Figure 12. Other Figure 13. Global Specialty Pharmaceutical Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Specialty Pharmaceutical Market Size 2016-2027 (US$ Million) Figure 15. Global Specialty Pharmaceutical Sales 2016-2027 (MT) Figure 16. Global Specialty Pharmaceutical Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Specialty Pharmaceutical Sales Share by Manufacturers in 2020 Figure 18. Global Specialty Pharmaceutical Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Specialty Pharmaceutical Players: Market Share by Revenue in 2020 Figure 20. Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Specialty Pharmaceutical Sales Market Share by Region (2016-2021) Figure 22. Global Specialty Pharmaceutical Sales Market Share by Region in 2020 Figure 23. Global Specialty Pharmaceutical Revenue Market Share by Region (2016-2021) Figure 24. Global Specialty Pharmaceutical Revenue Market Share by Region in 2020 Figure 25. the United States Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. UK Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. China Taiwan Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. UAE Specialty Pharmaceutical Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Specialty Pharmaceutical by Type (2016-2021) Figure 48. Sales Market Share of Specialty Pharmaceutical by Application (2016-2021) Figure 49. Sales Market Share of Specialty Pharmaceutical by Application in 2020 Figure 50. Revenue Share of Specialty Pharmaceutical by Application (2016-2021) Figure 51. Revenue Share of Specialty Pharmaceutical by Application in 2020 Figure 52. Manufacturing Cost Structure of Specialty Pharmaceutical Figure 53. Manufacturing Process Analysis of Specialty Pharmaceutical Figure 54. Specialty Pharmaceutical Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed
Pfizer Roche Amgen AbbVie Novo Nordisk Johnson & Johnson Sanofi-Aventis Merck Eli Lilly Novartis 3sbio Changchun High Tech CP Guojian Pharmacy Biotech Pharma Gelgen Biopharma Innovent
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients